SU649313A3 - Способ получени производных индола или их солей - Google Patents

Способ получени производных индола или их солей

Info

Publication number
SU649313A3
SU649313A3 SU762388420A SU2388420A SU649313A3 SU 649313 A3 SU649313 A3 SU 649313A3 SU 762388420 A SU762388420 A SU 762388420A SU 2388420 A SU2388420 A SU 2388420A SU 649313 A3 SU649313 A3 SU 649313A3
Authority
SU
USSR - Soviet Union
Prior art keywords
general formula
methyl
indole derivatives
salts
methyl radical
Prior art date
Application number
SU762388420A
Other languages
English (en)
Russian (ru)
Inventor
Трокслер Франц
Зееманн Фритц
Original Assignee
Сандос Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сандос Аг (Фирма) filed Critical Сандос Аг (Фирма)
Application granted granted Critical
Publication of SU649313A3 publication Critical patent/SU649313A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU762388420A 1975-08-15 1976-08-13 Способ получени производных индола или их солей SU649313A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (1)

Publication Number Publication Date
SU649313A3 true SU649313A3 (ru) 1979-02-25

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
SU762388420A SU649313A3 (ru) 1975-08-15 1976-08-13 Способ получени производных индола или их солей

Country Status (28)

Country Link
US (1) US4434176A (enExample)
JP (2) JPS5223073A (enExample)
AT (1) AT363070B (enExample)
AU (1) AU505719B2 (enExample)
BE (1) BE845197R (enExample)
CA (1) CA1080720A (enExample)
CY (1) CY1225A (enExample)
DE (1) DE2635209C2 (enExample)
DK (1) DK152120C (enExample)
ES (1) ES450681A1 (enExample)
FI (1) FI63751C (enExample)
FR (1) FR2320743A2 (enExample)
GB (2) GB1575509A (enExample)
HK (1) HK35884A (enExample)
IE (1) IE43797B1 (enExample)
IL (2) IL50263A (enExample)
KE (1) KE3404A (enExample)
MY (1) MY8500135A (enExample)
NL (2) NL176362C (enExample)
NO (1) NO762735L (enExample)
NZ (1) NZ181764A (enExample)
PH (1) PH13356A (enExample)
PT (1) PT65477B (enExample)
SE (1) SE414633B (enExample)
SG (1) SG84883G (enExample)
SU (1) SU649313A3 (enExample)
YU (1) YU198876A (enExample)
ZA (1) ZA764883B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
BRPI0410840A (pt) * 2003-05-30 2006-07-04 Ranbaxy Lab Ltd derivados substituìdos de pirrol, composição farmacêutica contendo os mesmos e processo para sua preparação
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
SE375771B (enExample) * 1970-09-30 1975-04-28 Sandoz Ag
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides

Also Published As

Publication number Publication date
IL50263A0 (en) 1976-10-31
HK35884A (en) 1984-05-04
MY8500135A (en) 1985-12-31
IE43797L (en) 1977-02-15
DE2635209A1 (de) 1977-02-24
BE845197R (fr) 1977-02-14
FR2320743A2 (fr) 1977-03-11
NL930134I2 (nl) 1996-11-01
GB1575510A (en) 1980-09-24
NL930134I1 (nl) 1993-11-01
PT65477A (fr) 1976-09-01
FI63751C (fi) 1983-08-10
ZA764883B (en) 1978-03-29
IL58163A0 (en) 1979-12-30
SE7608865L (sv) 1977-02-16
JPS5223073A (en) 1977-02-21
FI63751B (fi) 1983-04-29
NL7608902A (nl) 1977-02-17
IE43797B1 (en) 1981-06-03
SE414633B (sv) 1980-08-11
JPS568834B2 (enExample) 1981-02-25
PT65477B (fr) 1978-05-10
YU198876A (en) 1982-05-31
NO762735L (enExample) 1977-02-16
CA1080720A (en) 1980-07-01
AT363070B (de) 1981-07-10
DE2635209C2 (de) 1983-01-27
DK152120C (da) 1988-06-20
ATA602576A (de) 1980-12-15
JPS5649318A (en) 1981-05-02
DK357576A (da) 1977-02-16
NZ181764A (en) 1978-06-20
SG84883G (en) 1985-01-11
IL50263A (en) 1980-06-30
GB1575509A (en) 1980-09-24
KE3404A (en) 1985-02-01
US4434176A (en) 1984-02-28
NL176362B (nl) 1984-11-01
FR2320743B2 (enExample) 1978-11-17
FI762258A7 (enExample) 1977-02-16
CY1225A (en) 1984-04-06
ES450681A1 (es) 1977-11-16
NL176362C (nl) 1985-04-01
PH13356A (en) 1980-03-20
DK152120B (da) 1988-02-01
AU505719B2 (en) 1979-11-29
AU1684176A (en) 1978-02-16

Similar Documents

Publication Publication Date Title
SU520041A3 (ru) Способ получени амидов ароматических карбоновых кислот или их солей
SU509221A3 (ru) Способ получени 1,4-дигидро-пиридинов или их солей
SU451244A3 (ru) Способ получени производных фенилимидазолилалкила
SU865125A3 (ru) Способ получени производных имидазола или их солей
SU657744A3 (ru) Способ получени производных 3,4-диметил-5-оксо-2,5дигидропиррола
JPS6160077B2 (enExample)
SU649313A3 (ru) Способ получени производных индола или их солей
SU509231A3 (ru) Способ получени производныхморфолина
SU701536A3 (ru) Способ получени производных 1,2-бензизотиазолинона-3 или их кислотно-аддитивных солей
US4144397A (en) Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex
US4267355A (en) Production of herbicidally-active derivatives of alanine
SU747426A3 (ru) Способ получени дитиенилалкиламинов или их солей
US4091037A (en) Preparation of alkylthiomethylphenols
EP0052333B1 (en) 4-fluoro-5-oxypyrazole derivate and preparation thereof
SU489314A3 (ru) Способ получени замещенных эфиров карбаминовой кислоты
SU498912A3 (ru) Способ получени триазолотиазоловых эфиров кислот фосфора
US4450274A (en) Preparation of ethambutol-diisoniazide methane sulfonic acid salt
SU581860A3 (ru) Способ получени ацильных производных диангидрогекситов
US3803202A (en) Process for the production of 2-cyano-3,4,5,6-tetrahalogenbenzoic acid alkyl esters
SU415876A3 (ru) Способ получения производных бензимидазола
US3244725A (en) 4, 5-diacyl-3-hydroxy-3-pyrrolin-2-ones
GB2182927A (en) 3-perfluoroalkyl-5-hydroxyisoxazoles
SU520048A3 (ru) Способ получени 3пирролидинил-1-пропилдитиокарбаминовой кислоты
US3331859A (en) 3-aroyl-(2-arylmethyl)chromones
US4197405A (en) Thermolysis of 3'-(Aryl)-spiro[isobenzofuran-1(3H),5'(4'H)-isoxazol]-3-one